loadpatents
Patent applications and USPTO patent grants for Butcher; Eugene C..The latest application filed is for "dgat1 inhibition for treatment of demyelinating inflammatory disease".
Patent | Date |
---|---|
DGAT1 inhibition for treatment of demyelinating inflammatory disease Grant 10,226,470 - Graham , et al. | 2019-03-12 |
Function homology screening Grant 10,018,621 - Berg , et al. July 10, 2 | 2018-07-10 |
Methods of enhancing anti-tumor immunity by administering antibodies to the CCRL2 chemerin receptor Grant 9,868,792 - Zabel , et al. January 16, 2 | 2018-01-16 |
Dgat1 Inhibition For Treatment Of Demyelinating Inflammatory Disease App 20170095483 - Graham; Kareem ;   et al. | 2017-04-06 |
Mobilizing Anti-tumor Immunity By Targeting Chemerin Receptor Ccrl2 App 20170002087 - Zabel; Brian A. ;   et al. | 2017-01-05 |
Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy Grant 9,480,741 - Fabene , et al. November 1, 2 | 2016-11-01 |
Small molecule CMKLR1 antagonists in demyelinating disease Grant 9,265,738 - Graham , et al. February 23, 2 | 2016-02-23 |
Small Molecule CMKLR1 Antagonists in Demyelinating Disease App 20150025153 - Graham; Kareem ;   et al. | 2015-01-22 |
Tolerogenic populations of dendritic cells Grant 8,889,124 - Hadeiba , et al. November 18, 2 | 2014-11-18 |
Function Homology Screening App 20130266967 - Berg; Ellen L. ;   et al. | 2013-10-10 |
Anti-Leukocyte Recruitment Therapy for the Treatment of Seizures and Epilepsy App 20130230539 - Fabene; Paolo Francesco ;   et al. | 2013-09-05 |
Function homology screening Grant 8,467,970 - Berg , et al. June 18, 2 | 2013-06-18 |
Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy Grant 8,383,116 - Fabene , et al. February 26, 2 | 2013-02-26 |
Novel Target for Regulating Multiple Sclerosis App 20120064092 - Graham; Kareem ;   et al. | 2012-03-15 |
Target for regulating multiple sclerosis Grant 8,038,992 - Graham , et al. October 18, 2 | 2011-10-18 |
Function homology screening Grant 7,912,651 - Berg , et al. March 22, 2 | 2011-03-22 |
Patient classification Grant 7,908,089 - Berg , et al. March 15, 2 | 2011-03-15 |
Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy App 20100098714 - Fabene; Paolo Francesco ;   et al. | 2010-04-22 |
Methods For Screening For Modulators Of Ccrl2 App 20100092974 - Zabel; Brian A. ;   et al. | 2010-04-15 |
Tolerogenic Populations Of Dendritic Cells App 20100080816 - Hadeiba; Husein ;   et al. | 2010-04-01 |
Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy Grant 7,682,613 - Fabene , et al. March 23, 2 | 2010-03-23 |
Target For Regulating Multiple Sclerosis App 20090280113 - Graham; Kareem ;   et al. | 2009-11-12 |
Function Homology Screening App 20080070271 - Berg; Ellen L. ;   et al. | 2008-03-20 |
Biomap Analysis App 20080064041 - Plavec; Ivan ;   et al. | 2008-03-13 |
Function Homology Screening App 20080064056 - Berg; Ellen L. ;   et al. | 2008-03-13 |
Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy App 20080025992 - Fabene; Paolo Francesco ;   et al. | 2008-01-31 |
CMKLR regulation of adipogenesis and adipocyte metabolic function App 20070286863 - Sinal; Christopher ;   et al. | 2007-12-13 |
BioMAP analysis Grant 7,266,458 - Plavec , et al. September 4, 2 | 2007-09-04 |
Peptide inhibitors of RhoA signaling App 20050209147 - Laudanna, Carlo ;   et al. | 2005-09-22 |
Family of cystatin-related chemoattractant proteins App 20050202029 - Zabel, Brian A. ;   et al. | 2005-09-15 |
Modulation of systemic memory T cell trafficking App 20050169918 - Butcher, Eugene C. ;   et al. | 2005-08-04 |
Modulation of systemic memory T cell trafficking Grant 6,881,406 - Butcher , et al. April 19, 2 | 2005-04-19 |
Patient classification App 20040219592 - Berg, Ellen L. ;   et al. | 2004-11-04 |
Function homology screening App 20040157269 - Berg, Ellen L. ;   et al. | 2004-08-12 |
Patient classification Grant 6,763,307 - Berg , et al. July 13, 2 | 2004-07-13 |
Function homology screening App 20040063088 - Berg, Ellen L. ;   et al. | 2004-04-01 |
Method for identifying agents which modulate chemokine "MEC"-induced functions of CCR3 Grant 6,692,922 - Butcher , et al. February 17, 2 | 2004-02-17 |
Biomap characterization of biologically active agents Grant 6,656,695 - Berg , et al. December 2, 2 | 2003-12-02 |
BioMAP analysis App 20030138811 - Plavec, Ivan ;   et al. | 2003-07-24 |
Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion molecules App 20030133937 - Magnani, John L. ;   et al. | 2003-07-17 |
Function homology screening App 20030113807 - Berg, Ellen L. ;   et al. | 2003-06-19 |
Patient classification App 20030017445 - Berg, Ellen L. ;   et al. | 2003-01-23 |
Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion molecules Grant 6,465,434 - Magnani , et al. October 15, 2 | 2002-10-15 |
Method for identifying agents which modulate chemokine "MEC"-induced functions of CCR3 and/or CCR10 App 20020137107 - Butcher, Eugene C. ;   et al. | 2002-09-26 |
Leukocyte homing modulation Grant 6,387,884 - Magnani , et al. May 14, 2 | 2002-05-14 |
Modulation of systemic memory T cell trafficking App 20020019341 - Butcher, Eugene C. ;   et al. | 2002-02-14 |
Modulation of systemic memory T cell trafficking Grant 6,245,332 - Butcher , et al. June 12, 2 | 2001-06-12 |
Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules Grant 6,121,233 - Magnani , et al. September 19, 2 | 2000-09-19 |
Method of control leukocyte extravasation Grant 5,538,724 - Butcher , et al. July 23, 1 | 1996-07-23 |
Method to control leukocyte extravasation Grant 5,403,919 - Butcher April 4, 1 | 1995-04-04 |
Neutrophil LECAM-1 as indicator of neutrophil activation Grant 5,316,913 - Butcher , et al. May 31, 1 | 1994-05-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.